Alvotech reports results for the first quarter of 2025 and provides business update

Reykjavik, iceland, may 7, 2025 - alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first quarter of 2025 and provided a summary of recent pipeline and corporate highlights. management will conduct a business update conference call and live webcast on march 8, 2025, at 8:00 am et (12:00 pm gmt).
ALVO Ratings Summary
ALVO Quant Ranking